Journal of the American College of Surgeons
-
The delay of elective surgeries by the coronavirus 2019 (COVID-19) pandemic prompted concern among surgeons to delay estrogen receptor (ER)-negative ductal carcinoma in situ (DCIS) for fear of missing an ER-negative invasive cancer and compromising survival of patients. ⋯ Delays in surgery were associated with higher tumor upstage rates but not with worse overall survival.